Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1/Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  The Ottawa Hospital, Ottawa, Ontario – En cours

Collection of Tissue Samples for Cancer Research

• Condition:
  Multiple Myeloma
  
• Phase d'étude:
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Princess Margaret Hospital, Toronto, – En cours

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1/Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  University Health Network - Princess Margaret Cancer Center, Toronto, Ontario – Recrutement inactif

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude:
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Local Institute, Toronto, Ontario – En cours

  Local Institute, Weston, Ontario – En cours

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Foothills Hospital, Calgary, Alberta – Recrutement inactif

  Fraser Valley Centre, Surrey, British Columbia – Recrutement inactif

  British Columbia Cancer Agency, Vancouver, British Columbia – Recrutement inactif

  
  Autres centres
  
  

  Vitalite Health Network, Moncton, New Brunswick – Recrutement inactif

  Health Sciences Center, St John's, Newfoundland and Labrador – Recrutement inactif

  Princess Margaret Hospital University Health Network, Toronto, Ontario – Complet

  Princess Margaret Hospital, Toronto, Ontario – Recrutement inactif

  Royal Victoria Hospital, Montreal, Quebec – Recrutement inactif

Selinexor and Backbone Treatments of Multiple Myeloma Patients

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1/Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Center/Alberta Health Services, Calgary, Alberta – En cours

  Cross Cancer Institute / University of Alberta, Edmonton, Alberta – En cours

  Vancouver General Hospital, Vancouver,, British Columbia – Recrutement inactif

  
  Autres centres
  
  

  Cancer Care Manitoba, Winnipeg, Manitoba – Recrutement inactif

  Memorial Hospital of Newfoundland, St. John's, Newfoundland and Labrador – Recrutement inactif

  Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia – En cours

  Princess Margaret Cancer Centre, Toronto, Ontario – En cours

  Maisonneuve-Rosemont Hospital, Montreal, Quebec – Recrutement inactif

  Royal Victoria Hospital / McGill University, Montreal, Quebec – Recrutement inactif

AMG 176 First in Human Trial in Subjects With Relapsed or Refractory Multiple Myeloma and Subjects With Relapsed or Refractory Acute Myeloid Leukemia

• Condition:
  Leukemia
  Leukemia, Myeloid
  Multiple Myeloma
  Neoplasms, Plasma Cell
  Leukemia, Myeloid, Acute
  
• Phase d'étude: Phase 1
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Research Site, Calgary, Alberta – En cours

  Research Site, Toronto, Ontario – En cours

A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1/Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Centre, Calgary, Alberta – À venir

  Vancouver General Hospital, Vancouver, British Columbia – À venir

  Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia – À venir

  
  Autres centres
  
  

  McGill University Health Center - Royal Victoria Hospital, Montreal, Quebec – À venir

MMRF Molecular Profiling Protocol

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  Neoplasms
  
• Phase d'étude:
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Princess Margaret Cancer Centre, Toronto, Ontario – Recrutement inactif

Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario – En cours

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Unit 57, Special Services Building, Calgary, Alberta – En cours

  Tom Baker Cancer Centre, Calgary, Alberta – En cours

  Cross Cancer Institute, Edmonton, Alberta – En cours

  
  Autres centres
  
  

  University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario – En cours

  McGill University Health center, Montreal, Quebec – À venir

  MUHC, GLEN site, Montreal, Quebec – En cours

Dose-Escalation Study of BFCR4350A in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1
• Statut du recrutement: En cours

• Centres les plus proches:
  

  University of Calgary, Calgary, Alberta – À venir

  Princess Margaret Cancer Center, Toronto, Ontario – En cours

  Jewish General Hospital, Montreal, Quebec – En cours

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

• Condition:
  Multiple Myeloma
  Lymphoma, Non-Hodgkin
  
• Phase d'étude: Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Cross Cancer Institute, Edmonton, Alberta – En cours

  BCCA - Vancouver Cancer Centre, Vancouver, British Columbia – En cours

  Kingston Health Sciences Centre, Kingston, Ontario – En cours

  
  Autres centres
  
  

  London Regional Cancer Program, London, Ontario – En cours

  Ottawa Hospital Research Institute, Ottawa, Ontario – En cours

  University Health Network, Toronto, Ontario – En cours

  The Jewish General Hospital, Montreal, Quebec – En cours

  Allan Blair Cancer Centre, Regina, Saskatchewan – En cours

  Saskatoon Cancer Centre, Saskatoon, Saskatchewan – En cours

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1/Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Centre /ID# 167822, Calgary, Alberta – En cours

  Cross Cancer Institute /ID# 203114, Edmonton, Alberta – En cours

  Montreal General Hospital - McGill University Health Center /ID# 167824, Montreal, Quebec – En cours

A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1/Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Center, Calgary, Alberta – En cours

  Princess Margaret Cancer Centre, Toronto, Ontario – En cours

Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  Hematologic Neoplasms
  
• Phase d'étude: Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond, Montréal, Quebec – En cours

Multiple Myeloma Molecular Monitoring Study

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude:
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Centre, Calgary, Alberta – En cours

  Cross Cancer Institute, Edmonton, Alberta – En cours

  Vancouver General Hospital, Vancouver, British Columbia – À venir

  
  Autres centres
  
  

  CancerCare Manitoba, Winnipeg, Manitoba – En cours

  Saint John Regional Hospital (Horizon Health Network), Saint John, New Brunswick – En cours

  Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia – En cours

  The Ottawa Hospital, Ottawa, Ontario – À venir

  Princess Margaret Cancer Centre, Toronto, Ontario – En cours

  CIUSSS de l'Est-de-l'Île-de-Montréal (Maisonneuve-Rosemount), Montréal, Quebec – En cours

  McGill University Health Centre, Montréal, Quebec – En cours

ASA vs. Rivaroxaban in Newly Diagnosed or Relapsed and Refractory Multiple Myeloma Patients Treated With Len-Dex Combination Therapy.

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 2/Phase 3
• Statut du recrutement: En cours

• Centres les plus proches:
  

  London Health Sciences Centre, London, Ontario – En cours

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1/Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond, Montréal, Quebec – En cours

A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 3
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Centre /ID# 218846, Calgary, Alberta – À venir

  BC Cancer Agency /ID# 222804, Vancouver, British Columbia – À venir

  Qe Ii Hsc /Id# 218883, Halifax, Nova Scotia – À venir

  
  Autres centres
  
  

  CISSS-CA (Centre Integre de sante et de services sociaux de Chaudiere-Appalache) /ID# 218887, Levis, Quebec – En cours

To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  GSK Investigational Site, Montreal, Quebec – En cours

  GSK Investigational Site, Montreal, Quebec – En cours

Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 3
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer center, Calgary, Alberta – En cours

  Princess Margaret Cancer Centre, Toronto, Ontario – En cours

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

• Condition:
  Meningioma
  Uterine Neoplasms
  Colorectal Neoplasms, Hereditary Nonpolyposis
  Hamartoma Syndrome, Multiple
  Syndrome
  
• Phase d'étude:
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Princess Margaret Cancer Centre, Toronto, Ontario – En cours

Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1/Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Cross Cancer Institute, Edmonton, Alberta – En cours

  Vancouver General Hospital, Vancouver, British Columbia – En cours

  CancerCare Manitoba, Winnipeg, Manitoba – En cours

  
  Autres centres
  
  

  QEII Health Sciences Centre, Halifax, Nova Scotia – En cours

  Juravinski Cancer Centre, Hamilton, Ontario – À venir

  London Health Sciences Centre, London, Ontario – En cours

  The Ottawa Hospital, Ottawa, Ontario – En cours

  Princess Margaret Cancer Centre, Toronto, Ontario – En cours

  Allan Blair Cancer Centre, Regina, Saskatchewan – À venir

Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Centre, Calgary, Alberta – En cours

Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Princess Margaret Hospital, Toronto, Ontario – À venir

A Study to Desensitize Allergic Reactions to Treatments for Blood Disorders

• Condition:
  Multiple Myeloma
  Amyloidosis
  
• Phase d'étude: Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Princess Margaret Cancer Centre, Toronto, Ontario – En cours

A Study to Determine the Recommended Dose and Regimen and Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Subjects With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1/Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Center, Calgary, Alberta – En cours

  University of Alberta - Faculty of Medicine and Dentistry, Edmonton, Alberta – En cours

  Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia – En cours

  
  Autres centres
  
  

  Princess Margaret Cancer Centre, Toronto, Ontario – En cours

  Hopital Maisonneuve Rosemont dba CIUSSS de lEst de lIle de Montreal, Montreal, Quebec – En cours

Feasibility Study Comparing Enteral vs Parenteral Nutritional Outcomes in Autologous Stem Cell Transplant Patients

• Condition:
  Hematologic Neoplasms
  
• Phase d'étude: N/A
• Statut du recrutement: En cours

• Centres les plus proches:
  

  London Health Sciences Centre-Victoria Hospital, London, Ontario – En cours

A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Center, Calgary, Alberta – À venir

  Princess Margaret Cancer Centre, Toronto, Ontario – En cours

  Hopital Maisonneuve Rosemont dba CIUSSS de lEst de lIle de Montreal, Montreal, Quebec – À venir

Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1
• Statut du recrutement: En cours

• Centres les plus proches:
  

  GSK Investigational Site, Edmonton, Alberta – En cours

  GSK Investigational Site, London, Ontario – En cours

  GSK Investigational Site, Ottawa, Ontario – En cours

A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Centre, Calgary, Alberta – À venir

  Vancouver General Hospital, Vancouver, British Columbia – Retiré

  University Health Network (UHN) Princess Margaret Cancer Centre, Toronto, Ontario – À venir

Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 5)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  GSK Investigational Site, Vancouver, British Columbia – En cours

  GSK Investigational Site, Toronto, Ontario – En cours

Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 3
• Statut du recrutement: En cours

• Centres les plus proches:
  

  GSK Investigational Site, Edmonton, Alberta – En cours

A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Research Site 7, Toronto, Ontario – En cours

Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 3
• Statut du recrutement: En cours

• Centres les plus proches:
  

  GSK Investigational Site, Edmonton, Alberta – En cours

  GSK Investigational Site, London, Ontario – En cours

  GSK Investigational Site, Quebec City, Quebec – En cours

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Centre, Calgary, Alberta – En cours

Virtual Exercise for Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: N/A
• Statut du recrutement: En cours

• Centres les plus proches:
  

  University of Alberta/ Cross Cancer Institute, Edmonton, Alberta – En cours

A Study of Teclistamab, in Participants With Relapsed or Refractory Multiple Myeloma

• Condition:
  Multiple Myeloma
  Hematologic Neoplasms
  
• Phase d'étude: Phase 2
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Tom Baker Cancer Centre, Calgary, Alberta – En cours

  Cross Cancer Institute, Edmonton, Alberta – À venir

  University Health Network (UHN) Princess Margaret Cancer Centre, Toronto, Ontario – En cours

  
  Autres centres
  
  

  McGill University Health Centre, Montreal, Quebec – En cours

A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude: Phase 1
• Statut du recrutement: En cours

• Centres les plus proches:
  

  Alberta Health Services, Edmonton, Alberta – À venir

  McGill University Health Centre, Montreal, Quebec – À venir

Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)

• Condition:
  Multiple Myeloma
  Neoplasms, Plasma Cell
  
• Phase d'étude:
• Statut du recrutement: À venir

• Centres les plus proches:
  

  Cross Cancer Institute /ID# 224172, Edmonton, Alberta – ()

  Hopital Maisonneuver-Rosemont /ID# 224127, Montreal, Quebec – ()